In MOC2 head and neck cancer cells, we observed a dose dependent increase in the expression of Ifnβ1 and Mx1 that peaked at day 1 following radiation (Figure 1A-B), which is consistent with prior reports 42, 43. This evidence concerns the gene IFNB1 and head and neck cancer.